33445430|t|Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A.
33445430|a|BACKGROUND: DYT1 dystonia is the most common form of early-onset inherited dystonia, which is caused by mutation of torsin A (TA) belonging to the "ATPases associated with a variety of cellular activities" (AAA + ATPase). Dystonia is often accompanied by pain, and neuropathic pain can be associated to peripherally induced movement disorder and dystonia. However, no evidence exists on the effect of gabapentin in mice subjected to neuropathic pain model overexpressing human normal or mutated TA. METHODS: Mice subjected to L5 spinal nerve ligation (SNL) develop mechanical allodynia and upregulation of the alpha2delta-1 L-type calcium channel subunit, forming a validated experimental model of neuropathic pain. Under these experimental conditions, TA is expressed in dorsal horn neurons and astrocytes and colocalizes with alpha2delta-1. Similar to this subunit, TA is overexpressed in dorsal horn 7 days after SNL. This model has been used to investigate (1) basal mechanical sensitivity; (2) neuropathic pain phases; and (3) the effect of gabapentin, an alpha2delta-1 ligand used against neuropathic pain, in non-transgenic (NT) C57BL/6 mice and in mice overexpressing human wild-type (hWT) or mutant (hMT) TA. RESULTS: In comparison to non-transgenic mice, the threshold for mechanical sensitivity in hWT or hMT does not differ (Kruskal-Wallis test = 1.478; p = 0.4777, although, in the latter animals, neuropathic pain recovery phase is delayed. Interestingly, gabapentin (100 mg/Kg) reduces allodynia at its peak (occurring between post-operative day 7 and day 10) but not in the phase of recovery. CONCLUSIONS: These data lend support to the investigation on the role of TA in the molecular machinery engaged during neuropathic pain.
33445430	10	20	Gabapentin	Chemical	MESH:D000077206
33445430	26	42	Neuropathic Pain	Disease	MESH:D009437
33445430	52	56	Mice	Species	10090
33445430	72	77	Human	Species	9606
33445430	91	96	Human	Species	9606
33445430	105	113	Torsin A	Gene	1861
33445430	127	131	DYT1	Gene	1861
33445430	132	140	dystonia	Disease	MESH:D004421
33445430	180	198	inherited dystonia	Disease	MESH:D020821
33445430	231	239	torsin A	Gene	1861
33445430	241	243	TA	Gene	1861
33445430	337	345	Dystonia	Disease	MESH:D004421
33445430	370	374	pain	Disease	MESH:D010146
33445430	380	396	neuropathic pain	Disease	MESH:D009437
33445430	439	456	movement disorder	Disease	MESH:D009069
33445430	461	469	dystonia	Disease	MESH:D004421
33445430	516	526	gabapentin	Chemical	MESH:D000077206
33445430	530	534	mice	Species	10090
33445430	548	564	neuropathic pain	Disease	MESH:D009437
33445430	586	591	human	Species	9606
33445430	610	612	TA	Gene	1861
33445430	623	627	Mice	Species	10090
33445430	667	670	SNL	Disease	MESH:D061227
33445430	680	700	mechanical allodynia	Disease	MESH:D006930
33445430	813	829	neuropathic pain	Disease	MESH:D009437
33445430	983	985	TA	Gene	1861
33445430	1031	1034	SNL	Disease	MESH:D061227
33445430	1114	1130	neuropathic pain	Disease	MESH:D009437
33445430	1161	1171	gabapentin	Chemical	MESH:D000077206
33445430	1210	1226	neuropathic pain	Disease	MESH:D009437
33445430	1251	1258	C57BL/6	CellLine	CVCL:C0MU
33445430	1259	1263	mice	Species	10090
33445430	1271	1275	mice	Species	10090
33445430	1291	1296	human	Species	9606
33445430	1329	1331	TA	Gene	1861
33445430	1374	1378	mice	Species	10090
33445430	1526	1542	neuropathic pain	Disease	MESH:D009437
33445430	1585	1595	gabapentin	Chemical	MESH:D000077206
33445430	1616	1625	allodynia	Disease	MESH:D006930
33445430	1842	1858	neuropathic pain	Disease	MESH:D009437
33445430	Association	MESH:D020821	1861
33445430	Negative_Correlation	MESH:D000077206	MESH:D006930
33445430	Negative_Correlation	MESH:D000077206	MESH:D009437
33445430	Association	MESH:D004421	1861
33445430	Positive_Correlation	MESH:D061227	1861

